跳至主要内容
临床试验/IRCT20141201020178N10
IRCT20141201020178N10招募中2 期

actobacillus reuteri Supplementation versus Standard Triple Therapy for Helicobacter pylori Eradication among Patients with Dyspepsia

Iran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Patients aged between 18 to 70 years old with dyspepsia presentation
  • H. Pylori documentation by antral biopsy (Rapid Urease Test or Giemsa staining) or Urea Breath Test

排除标准

  • Pregnancy or breast- feeding
  • Women taking oral contraceptive pill (OCP)
  • Significant underlying diseases such as cardiac, pulmonary, renal, liver, endocrine, central nervous system (CNS) diseases and cancers
  • Previous history of gastric surgery
  • Patients taking triple therapy for H. Pylori eradication
  • History of taking proton pump inhibitor (PPI), histamine H2- receptor blocker (H2B) or antibiotic during previous two weeks
  • Concomitant use of anticoagulant or corticosteroid
  • Previous history of taking monoamine oxidase (MAO) inhibitors or tricyclic antidepressants (TCA)

研究者

相似试验